Tübingen Center for Academic Drug Discovery & Development (TüCAD2)
Eberhard Karls University Tübingen
Auf der Morgenstelle 8
D-72076 Tübingen
Germany
eMail: thanigaimalai.pillaiyarspam prevention@uni-tuebingen.de
Tel.: (+49 7071) 29 – 77458
https://www.scopus.com/authid/detail.uri?authorId=56840856900&source=sd-apx
ORCID: https://orcid.org/0000-0001-5575-8896
https://scholar.google.com/citations?user=fWe-t7AAAAAJ&hl=en
CV (pdf)
Thanigaimalai Pillaiyar earned his master’s degree in chemistry from Bharathiar University, Tamil Nadu, India, in 2006. Before his Ph.D., he worked for one year as a Research Executive at Orchid Chemicals and Pharmaceuticals Limited in Tamil Nadu. He completed his Ph.D. in Medicinal Chemistry in 2011 under the supervision of Prof. Dr. Sang-Hun Jung at Chungnam National University, South Korea. Following that, he spent two years at Tokyo University of Pharmacy and Life Sciences, Japan, as a Postdoctoral Fellow supported by the Japan Society for the Promotion of Science, working in the lab of Prof. Dr. Yoshio Hayashi. In 2013, he secured a two-year Alexander von Humboldt Postdoctoral Fellowship to work with Prof. Dr. Christa E. Müller at the University of Bonn, Germany. In 2020, he served as a visiting scientist for two months in Prof. Steven V. Ley’s laboratory at the University of Cambridge. That same year, he joined Eberhard Karls University Tübingen’s Tübingen Center for Academic Drug Discovery & Development (TüCAD2) as an Independent Junior Research Group Leader.
Pillaiyar’s research interests include medicinal chemistry for developing modulators—both agonists and antagonists—for various GPCRs, especially orphan GPCRs, and broad-spectrum antiviral agents targeting emerging zoonotic viruses with potential for future outbreaks.
Publications (pdf)
- Original works
- Patents
- Books and book chapters
